A 13-year-old presents with progressive gait ataxia, absent lower-extremity reflexes, pes cavus, scoliosis, hypertrophic cardiomyopathy, and impaired proprioception. Which disease-modifying therapy received FDA approval in 2023?
- AIdebenone
- BOmaveloxolone (Skyclarys) for Friedreich ataxia
- CCoenzyme Q10
- DNusinersen